DiNardo, Andrew R.
Arditi, Moshe
Kamat, Ashish M.
Koster, Kent J.
Carrero, Santiago
Nishiguchi, Tomoki
Lebedev, Maxim
Benjamin, Aaron B.
Avalos, Pablo
Lozano, Marisa
Moule, Madeleine G.
McCune, Brittany
Herron, Baysia
Ladki, Malik
Sheikh, Daanish
Spears, Matthew
Herrejon, Ivan A.
Dodge, Courtney
Kumar, Sathish
Hutchison, Robert W.
Ofili, Theresa U.
Opperman, Lynne A.
Bernard, Jessica A.
Lerner, Seth P.
Udeani, George
Neal, Gabriel
Netea, Mihai G.
Cirillo, Jeffrey D. http://orcid.org/0000-0003-3058-2702
Funding for this research was provided by:
Texas A and M University
Article History
Received: 29 January 2023
Accepted: 19 September 2023
First Online: 4 October 2023
Declarations
:
: The trial has been approved separately by the individual institutional IRB for each institution: Texas A&M University, Baylor College of Medicine, UT MD Anderson Cancer Center, and Cedars-Sinai Medical Center. Before participating, all subjects signed a consent form electronically. We declare and certify that this trial has received ethical approval from the appropriate ethical committee as described above.
: Not applicable - no identifying images or other personal or clinical details of participants are presented here or will be presented in reports of the trial results. Informed consent materials are attached as supplementary materials - Appendix InternalRef removed.
: The authors declare that they have no competing interests.